NEW YORK, Dec. 15, 2017 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Synergy Pharmaceuticals, Inc. ("Synergy" or the "Company") (NASDAQ: SGYP).
If you invested in Synergy stock or options between September 5, 2017 and November 13, 2017 and would like to discuss your legal rights, click here: www.faruqilaw.com/SGYP. There is no cost or obligation to you.
You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to firstname.lastname@example.org.
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
Telephone: (877) 247-4292 or (212) 983-9330
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
View original content with multimedia:http://www.prnewswire.com/news-releases/synergy-pharmaceuticals-investor-alert-faruqi--faruqi-llp-encourages-investors-who-suffered-losses-exceeding-50000-investing-in-synergy-pharmaceuticals-inc-to-contact-the-firm-300572205.html
SOURCE Faruqi & Faruqi, LLP